| P50 | author | Davey Smith | Q73235334 |
| | Sara Gianella | Q90282543 |
| P2093 | author name string | J Sonya Haw | |
| | Jill Blumenthal | |
| | Brooke Sullivan | |
| P2860 | cites work | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
| | Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men | Q24612082 |
| | Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices | Q28067469 |
| | The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices | Q28072780 |
| | Transgender stigma and health: A critical review of stigma determinants, mechanisms, and interventions | Q28083930 |
| | Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 | Q29395472 |
| | Global health burden and needs of transgender populations: a review. | Q30249507 |
| | Priorities for transgender medical and healthcare research. | Q30359711 |
| | Ensuring an inclusive global health agenda for transgender people | Q30378540 |
| | Do ask, do tell: high levels of acceptability by patients of routine collection of sexual orientation and gender identity data in four diverse American community health centers | Q30848208 |
| | Electronic health records and transgender patients--practical recommendations for the collection of gender identity data | Q30882814 |
| | Racial/ethnic disparities in history of incarceration, experiences of victimization, and associated health indicators among transgender women in the U.S. | Q33718759 |
| | Correlates of antiretroviral adherence and viral load among transgender women living with HIV | Q33745457 |
| | Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection | Q33779655 |
| | Transmen: the HIV risk of gay identity | Q46165003 |
| | Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline | Q46260846 |
| | Transgender Population Size in the United States: a Meta-Regression of Population-Based Probability Samples. | Q53230043 |
| | Gender abuse, depressive symptoms, and HIV and other sexually transmitted infections among male-to-female transgender persons: a three-year prospective study | Q84376500 |
| | Antiretroviral therapy adherence among transgender women living with HIV. | Q33811773 |
| | Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception | Q34060282 |
| | Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy | Q34325526 |
| | Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review | Q34662288 |
| | Estradiol reduces susceptibility of CD4+ T cells and macrophages to HIV-infection | Q34685567 |
| | Testosterone replacement therapy among HIV-infected men in the CFAR Network of Integrated Clinical Systems | Q35233159 |
| | Select host restriction factors are associated with HIV persistence during antiretroviral therapy | Q35271996 |
| | Evaluation of respondent-driven sampling. | Q35752128 |
| | Legal Protections in Public Accommodations Settings: A Critical Public Health Issue for Transgender and Gender-Nonconforming People | Q36054075 |
| | Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy | Q36181422 |
| | Sexual risk behaviors and psychosocial health concerns of female-to-male transgender men screening for STDs at an urban community health center | Q36252397 |
| | Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness | Q36395963 |
| | HIV prevention and primary care for transgender women in a community-based clinic | Q36500953 |
| | "Bundling" HIV prevention: integrating services to promote synergistic gain | Q36513558 |
| | Syndemics and gender affirmation: HIV sexual risk in female-to-male trans masculine adults reporting sexual contact with cisgender males | Q36703538 |
| | Advancing methods for US transgender health research | Q37028595 |
| | 17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription | Q37043012 |
| | Design Issues in Transgender Studies | Q37114530 |
| | Exploring barriers and facilitators to participation of male-to-female transgender persons in preventive HIV vaccine clinical trials | Q37141939 |
| | Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research | Q37143401 |
| | Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives | Q37157697 |
| | HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial | Q37418247 |
| | Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus | Q37587086 |
| | Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. | Q38069264 |
| | Hypogonadism in the HIV-infected man. | Q38244429 |
| | Transgender people: health at the margins of society. | Q38870866 |
| | HIV Infection in Hard-to-Reach Populations. | Q39007916 |
| | Transgender Women Living with HIV Frequently Take Antiretroviral Therapy and/or Feminizing Hormone Therapy Differently Than Prescribed Due to Drug-Drug Interaction Concerns | Q40065014 |
| | Testosterone and sexual risk among transmen: a mixed methods exploratory study | Q40610798 |
| | HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study. | Q42226035 |
| | Effect of sex steroid hormones on replication and transmission of major HIV subtypes | Q42268597 |
| | Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry | Q42286793 |
| | Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives | Q42628968 |
| | A two-question method for assessing gender categories in the social and medical sciences | Q43618932 |
| | Recent trauma is associated with antiretroviral failure and HIV transmission risk behavior among HIV-positive women and female-identified transgenders | Q43825293 |
| | Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss. | Q45197385 |
| | Estrogen stimulates transcription of human immunodeficiency virus type 1 (HIV-1). | Q45421017 |
| | Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels | Q45753738 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1460-1466 | |
| P577 | publication date | 2017-11-08 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | The Importance of HIV Research for Transgender and Gender Non-Binary Individuals | |
| P478 | volume | 66 | |